PrescriptionDrugs.org

What to Expect When Starting Clindamycin

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Clindamycin is a lincosamide antibiotic effective against gram-positive bacteria and anaerobes, commonly used for skin infections, dental infections, bone infections, and as an alternative for penicillin-allergic patients. It works by inhibiting bacterial protein synthesis. While effective, clindamycin carries one of the highest risks among antibiotics for causing Clostridioides difficile (C. diff) colitis, a potentially serious intestinal infection.

Week-by-week timeline

Day 1-2

Starting Treatment

Clindamycin is typically dosed 3-4 times daily (every 6-8 hours) for oral formulations, or can be IV in hospital settings. Symptoms of the infection should begin improving within 1-3 days. Take with a full glass of water and food to reduce esophageal irritation and GI upset.

Day 3-7

Infection Improving, GI Monitoring

The infection being treated should be clearly responding. GI side effects — nausea, diarrhea, abdominal cramping — are common with clindamycin and can be significant. Loose stools or mild diarrhea may be tolerable. However, watch carefully for signs of C. diff colitis.

Week 1-2

Completing the Full Course

Complete the full prescribed course (typically 7-14 days). Report significant diarrhea — more than 3-4 loose stools per day, especially with cramping or blood. Severe diarrhea during or after clindamycin must be evaluated for C. diff.

Post-Treatment (Weeks 1-4)

C. diff Monitoring

C. diff colitis can develop during treatment or up to 4-8 weeks after completing clindamycin. If severe diarrhea with cramping develops in the weeks after finishing clindamycin, contact your doctor and mention you recently took clindamycin.

Recovery

Resolution

Most infections treated appropriately with clindamycin resolve completely. If symptoms of the original infection return, contact your provider. Probiotic supplementation during and after antibiotic courses may reduce GI side effects, though evidence for C. diff prevention is mixed.

When to call your doctor

Contact your healthcare provider if you experience:

  • Severe or bloody diarrhea, abdominal cramping, or mucus in stools during or after treatment (possible C. diff colitis — seek care promptly)
  • High fever with diarrhea (possible severe C. diff)
  • Difficulty swallowing or chest pain after oral doses (esophageal irritation — take with a full glass of water and remain upright for 30 minutes)
  • Severe skin rash, blistering, or peeling (serious skin reaction)
  • Signs of liver problems: yellowing of skin or eyes, abdominal pain
  • Severe allergic reaction: hives, difficulty breathing, facial swelling
  • Muscle weakness if used in patients with myasthenia gravis (clindamycin can worsen neuromuscular blockade)

Tips for getting started

Take each dose with a full glass of water (at least 8 oz) and food to prevent esophageal irritation and GI upset. Do not lie down for at least 30 minutes after taking an oral dose. Complete the full course. Monitor yourself for significant diarrhea during and for several weeks after treatment — C. diff can develop late. Tell your doctor immediately if you develop severe diarrhea. Do not use anti-diarrheal medications (Imodium) if C. diff is suspected, as slowing gut motility can worsen the infection.

Frequently asked questions

More about Clindamycin

References

  1. [Regulatory] FDA Label: Clindamycin Hydrochloride Capsules https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050406s035lbl.pdf Accessed 2026-03-01.
  2. [Regulatory] NIH MedlinePlus: Clindamycin https://medlineplus.gov/druginfo/meds/a682399.html Accessed 2026-03-01.
  3. [Regulatory] CDC: Clostridioides difficile Infection https://www.cdc.gov/cdiff/index.html Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: